107 related articles for article (PubMed ID: 23947734)
1. Commentary on Krupitsky et al.(2013): Refuge from the streets--parked on methadone, or seeking shelter of a depot?
Bell J
Addiction; 2013 Sep; 108(9):1638-9. PubMed ID: 23947734
[No Abstract] [Full Text] [Related]
2. [Documented effect of methadone, but not naltrexone].
Heilig M
Lakartidningen; 2002 Feb; 99(6):551-2. PubMed ID: 11881232
[No Abstract] [Full Text] [Related]
3. Injectable extended-release naltrexone for opioid dependence.
Woody GE; Metzger DS
Lancet; 2011 Aug; 378(9792):664-5; author reply 666. PubMed ID: 21856476
[No Abstract] [Full Text] [Related]
4. Promise of extended-release naltrexone is a red herring.
Bart G
Lancet; 2011 Aug; 378(9792):663; author reply 663-4. PubMed ID: 21856474
[No Abstract] [Full Text] [Related]
5. Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.
Carreño JE; Alvarez CE; Narciso GI; Bascarán MT; Díaz M; Bobes J
Addict Biol; 2003 Dec; 8(4):429-38. PubMed ID: 14690879
[TBL] [Abstract][Full Text] [Related]
6. Concerns about injectable naltrexone for opioid dependence.
Wolfe D; Carrieri MP; Dasgupta N; Wodak A; Newman R; Bruce RD
Lancet; 2011 Apr; 377(9776):1468-70. PubMed ID: 21529930
[No Abstract] [Full Text] [Related]
7. Injectable extended-release naltrexone for opioid dependence.
Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
Lancet; 2011 Aug; 378(9792):665; author reply 666. PubMed ID: 21856477
[No Abstract] [Full Text] [Related]
8. Excess mortality among opioid-using patients treated with oral naltrexone in Australia.
Degenhardt L; Larney S; Kimber J; Farrell M; Hall W
Drug Alcohol Rev; 2015 Jan; 34(1):90-6. PubMed ID: 25302627
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy and Naltrexone Pharmacotherapy.
Jones CW; Terplan M
Obstet Gynecol; 2018 Oct; 132(4):923-925. PubMed ID: 30204703
[TBL] [Abstract][Full Text] [Related]
10. Injectable extended-release naltrexone for opioid dependence.
Throckmorton DC; Temple R; Rappaport BA; Roca R; Winchell CJ
Lancet; 2011 Aug; 378(9792):665-6; author reply 666. PubMed ID: 21856478
[No Abstract] [Full Text] [Related]
11. [Evolution and update of detoxification techniques for opiate addicts].
Yui K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):175-7. PubMed ID: 11215403
[No Abstract] [Full Text] [Related]
12. Clinical treatment of opioid addiction and dependence.
Ling W; Rawson RA; Compton M
Methods Mol Med; 2003; 84():285-95. PubMed ID: 12703332
[No Abstract] [Full Text] [Related]
13. Response to Degenhardt et al.: 'depot naltrexone use for opioid dependence in Australia: large-scale use of an unregistered medication in the absence of data on safety and efficacy'.
Brewer C
Drug Alcohol Rev; 2008 Jul; 27(4):447-8; author reply 448-9. PubMed ID: 18584398
[No Abstract] [Full Text] [Related]
14. [Long-acting naltrexone--a new way out of opiate addiction?].
Stavseth LS; Kunøe N; Tanum L
Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2231-2. PubMed ID: 24226324
[No Abstract] [Full Text] [Related]
15. A 'miracle cure' misunderstood.
Brewer C
Addiction; 2012 Aug; 107(8):1528. PubMed ID: 22594709
[No Abstract] [Full Text] [Related]
16. Unexpected delirium during Rapid Opioid Detoxification (ROD).
Golden SA; Sakhrani DL
J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
[TBL] [Abstract][Full Text] [Related]
17. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
Chen TJ; Blum K; Payte JT; Schoolfield J; Hopper D; Stanford M; Braverman ER
Med Hypotheses; 2004; 63(3):538-48. PubMed ID: 15288384
[TBL] [Abstract][Full Text] [Related]
18. Ensuring the safety of new medications and devices: are naltrexone implants safe?
Wodak AD; Ali R; Henry D; Sansom L
Med J Aust; 2008 Apr; 188(8):438-9. PubMed ID: 18429707
[No Abstract] [Full Text] [Related]
19. [Use of naltrexone in the treatment of young drug addicts].
Waal H; Aamodt Ø; Olsen H
Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1662-4. PubMed ID: 12821983
[TBL] [Abstract][Full Text] [Related]
20. Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness.
Krupitsky E; Nunes EV; Ling W; Gastfriend DR; Memisoglu A; Silverman BL
Addiction; 2013 Sep; 108(9):1628-37. PubMed ID: 23701526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
